At Atlantic Therapeutics, our focus is on the treatment of incontinence, sexual health dysfunctions and other associated disorders, and are on a mission to help the millions of people suffering globally by strengthening the muscles and modulating the nerves of the pelvic floor.

We develop and manufacture medical device-quality pelvic floor strengthening and nerve stimulation products — all backed by strong clinical evidence and subjected to controlled trials. Healthcare professionals across the world rely on Atlantic Therapeutics to improve thousands of lives every year. All Atlantic Therapeutics Group Ltd. products are certified under the European Medical Devices Directive 93/42/EEC.

With 1 in 3 women and 1 in 10 men experiencing urinary incontinence to some degree every single day, estimating that around 400 million people globally are suffering, we have a huge opportunity to transform lives every day by helping to restore their bladder control and confidence.

Our Vision & Mission statements


To improve the quality of life of millions of people each year, by enabling them to restore and strengthen their pelvic health, this regaining the confidence and control to lead and active lives.


  1. To provide the most effective, non-invasive, safe and comfortable treatment to restore pelvic health
  2. To enable users to overcome the physical, emotional and financial consequences of pelvic health issues
  3. To raise awareness and educate the people about pelvic health, explaining that symptoms are completely natural and prevalent yet absolutely reversible

INNOVO – a proven solution to stress urinary incontinence

INNOVO is the principal innovation from Atlantic Therapeutics, a clinically proven and FDA approved medical device and the first completely non-invasive pelvic floor exerciser for at-home use. Designed by a team of clinical experts including Physiotherapist Dr Ruth Maher, INNOVO has provided over 4 million successful sessions across the globe with zero serious events reported. Recommended by 98% of physicians and 90% of users, INNOVO is the perfect solution for treating stress urinary incontinence2.

Easy to use, comfortable to wear and clinically proven to work, INNOVO helps patients safely and effortlessly treat bladder weakness by strengthening and re-educating the entire network of pelvic floor muscles through gentle muscle stimulation.

INNOVO is made of breathable, skin-friendly material, and is available in a wide range of sizes. The simple pull-on shorts design makes using the therapy at home simple and hassle-free. Suitable for women and men of all ages.

80 %

of users saw a significant improvement after 4 weeks3

87 %

of users saw were defined as dry or near dry after 12 weeks2

90 %

of users would recommend the therapy to others4

Unique Multipath™ technology.

INNOVO’s Multipath™ technology uses Electrical Muscle Stimulation (EMS) to deliver 180 perfect and complete contractions to the entire pelvic floor muscle network in each 30-minute session. It’s a proven technology designed to optimally strengthen and re-educate the muscles that control bladder function.

You're in control.

A hand-held controller connects to a pair of shorts and allows you to vary the intensity of the muscle stimulations – feel your entire pelvic floor lifting and releasing!

INNOVO is comfortable (there are no probes to insert) and is safer to use than any other EMS therapy2.

See results in as little as 4 weeks

All you need is 30 minutes a day, 5 days a week for up to 12 weeks for long-lasting results.

Just pull on INNOVO like a pair of shorts, connect the cables, and let it do those tricky pelvic floor exercises for you.

How INNOVO works

Control leaks in weeks! Easy, comfortable and pain-free. INNOVO makes it simple to treat bladder weakness in the comfort of home.

Week 1

Start using INNOVO for 30 minutes a day/5 days a week, increasing program intensity as you progress.

Week 4

Your pelvic floor muscles are getting stronger and you’re experiencing fewer leaks.

Week 12

You’re completely dry or very close. Your program intensity is now at the highest level.

Swipe to view timeline

See INNOVO’s clever technology in action

How does INNOVO contract the pelvic floor muscle externally? INNOVO's clever Multipath™ technology sends gentle muscle stimulations from the electrodes on the buttocks to the electrodes at the front. A patented criss-cross pattern stimulates the pelvic floor muscle at the centre, completely non-invasively and completely painlessly.

Supporting our community

We collaborate with the World Federation of Incontinence Patients (WFIP), a global organisation for sufferers of incontinence and related pelvic floor disorders, and together we want to promote the worldwide interests of these patients and help break the taboos surrounding these conditions.

We also work closely with patient groups in markets we are available.


Atlantic Therapeutics holds a Green Dot® license, which reflects our commitment to sustainable resource usage. For each piece of INNOVO packaging produced, a financial contribution is made to the end recovery of the packaging.

What's more, adult diapers and pads take an extraordinary 500 years to decompose so with INNOVO, you're also helping reduce landfill.

The INNOVO Story

With Dr. Ruth Maher & Dr. Sherry Ross
What people say about INNOVO

In 2017, Atlantic Therapeutics completed a €15m Series A growth capital financing. This was followed by a further €28m in a Series B round enabling the company to move forward with the next phase of growth and treat millions of people across the globe who suffer from bladder weakness, clinically known as stress urinary incontinence.

The funds come from a combination of venture capital investment from LSP, Seroba Life Sciences, Earlybird Venture Capital, as well as Bio-medical Research Group Ltd (previous owner) which retains a minority shareholding. The capital enables Atlantic Therapeutics to accelerate growth from INNOVO technology platform via market and geographic expansion and new product development.

Board of Directors

  • Susan Trent, Chief Executive Officer
  • Dr Daniel O’Mahony, Seroba Life Sciences
  • Anne Portwich, LSP
  • Thom Rasche, Earlybird Venture Capital
  • Aneta Sottil, Andera Partners
  • Paul Murray, Atlantic Bridge Ventures
  • Dr Bernard Collins, Biomedical Research

Clinical Advisory Board Members

  • Professor Roger Dmochowski – Professor at the Department of Urology and Director of the Section of Female Pelvic Medicine at Vanderbilt University in Nashville, USA
  • Professor Ruth Maher - Philadelphia College of Osteopathic Medicine Georgia in the Department of physical therapy and co-Inventor of INNOVO®, USA
  • Professor at
  • Professor Linda Cardozo - Professor of Urogynaecology and Consultant Gynaecologist at King's College Hospital, UK
  • Mr Ash Monga - Consultant gynaecologist and sub-specialist urogynaecologist in the Southampton University Hospital, UK
  • Willy Davila, MD - Chairman of the Department of Gynecology and Head of Urogynecology and Reconstructive Pelvic Surgery at Cleveland Clinic Florida in Weston, Florida, USA
  • Peter Sand MD - Dr Sand has over 100 scientific publications in the medical literature. Dr Sand is director of the Evanston Continence Center and the Continence Center at Stone Medical Building. USA
  • Sonja Soeder - Head of the German Pelvic floor centre in Berlin, EU
  • David Kaysen - Former CEO of Uroplasty, Diametrics Medical and Compex Technologies. USA
  • Michael Gambla MD - Urologist specialist MD in Columbus, OH, USA
  • Diane Newmann MD - Nurse Practitioner (NP), Co-Director, Penn Center for Continence and Pelvic Health, Director, Clinical Trials, Division of Urology and Adjunct Professor of Urology in Surgery

Get in touch!

Atlantic Therapeutics’ offices are located in Galway, Ireland; London, UK; Boston, USA; Paris, France; and Salem, Germany, so if you’d like to pop in for a visit and say ‘hello’, ‘bonjour’, or ‘hallo’, you’re always welcome!

Otherwise, you can give us a call on:

Ireland: 1800 800 045

London: 0800 028 5687

United States of America: 833-891-6391

Paris: 0805 542 027

Germany: 0800 589 4965


2 R. Dmochowski – Novel external electrical muscle stimulation device for the treatment of female stress urinary incontinence: randomized controlled noninferiority trial versus intravaginal electrical stimulation. ICS Conference 2018

3 Soeder S, et al, A randomised, controlled, double-blind, clinical study to compare two neuromuscular stimulator devices in female stress urinary incontinence: Effects on symptoms and quality of life. IUGA Conference 2018

4 Observational study on the treatment of stress urinary incontinence with Innovotherapy, April 2014

loading-circle icon